Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Emmaus Life Sciences Inc (QX) | EMMA | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.10 | 07:13:29 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.10 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.0506 - 0.33 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.10 | USD |
Emmaus Life Sciences Inc (QX) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 148.58M | 53.64M | 279.17k | 18.39M | -10.63M | -0.20 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Emmaus Life Sciences (QX) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EMMA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.10155 | 0.11 | 0.10 | 0.101563 | 3,325 | -0.00155 | -1.53% |
| 1 Month | 0.11375 | 0.11375 | 0.092107 | 0.0942888 | 10,874 | -0.01375 | -12.09% |
| 3 Months | 0.08939 | 0.13215 | 0.0786 | 0.1111482 | 13,814 | 0.01061 | 11.87% |
| 6 Months | 0.10 | 0.135 | 0.0506 | 0.1032058 | 33,340 | 0.00 | 0.00% |
| 1 Year | 0.30 | 0.33 | 0.0506 | 0.130578 | 31,550 | -0.20 | -66.67% |
| 3 Years | 1.18 | 4.00 | 0.0506 | 0.5347023 | 22,504 | -1.08 | -91.53% |
| 5 Years | 2.7525 | 4.00 | 0.0506 | 1.01 | 22,865 | -2.65 | -96.37% |
Emmaus Life Sciences (QX) Description
| Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease. |
